<DOC>
	<DOCNO>NCT00306865</DOCNO>
	<brief_summary>This study examine chemical change brain produce symptom hand dystonia . Patients dystonia muscle spasm cause uncontrolled twist repetitive movement abnormal posture . In focal dystonia , one part body , hand , neck face , involve . The study use positron emission tomography ( PET ) find area brain patient focal hand dystonia differ healthy volunteer without focal hand dystonia . Healthy volunteer patient focal hand dystonia 18 65 year age may eligible study . Candidates screen medical history physical neurological examination . Participants undergo follow procedure : - PET scanning : The PET scanner shape like doughnut . The subject lie bed slide scanner . A custom-molded plastic mask place face head support head prevent move scan . Two radioactive substance - five dos ( one per scan ) [ 15 O ] water one dose [ 11C ] flumazil inject body vein . The dose inject radioactive substance small , harmful body . The [ 15 O ] water dos inject first hour scan take every 10 minute . The [ 11C ] flumazil injected second hour . The radioactive substance detect PET scanner provide information functioning brain chemistry . - MRI scanning : MRI use magnetic field radio wave produce image body tissue organ . The patient lie table move scanner ( narrow cylinder ) , wear earplug muffle loud knock thump sound occur scan process . Scanning time study le one hour . Subjects may ask lie still 10 minute time .</brief_summary>
	<brief_title>Brain Changes Patients With Focal Hand Dystonia</brief_title>
	<detailed_description>Objective The purpose study determine focal hand dystonia disinhibition involve key structure motor control system ( basal ganglion , thalamus , cerebellum motor cortex ) cause dysfunction GABA-ergic neuron . The major inhibitory neurotransmitter central nervous system gamma-amino butyric acid ( GABA ) , act mainly GABA A receptor , majority posse benzodiazepine bind site . Pathological process involve GABA-ergic neuron cause alteration density GABA receptor , visualize measure positron emission tomography ( PET ) use radioactive ligand [ ( 11 ) C ] Flumazenil . Study Population This research conduct use 20 patient primary focal hand dystonia 20 healthy volunteer match age gender . Design By use positron emission tomography ( PET ) use radioactive ligand [ ( 11 ) C ] Flumazenil , detect alteration density GABA receptor patient primary focal hand dystonia comparison control subject . Outcome Measures We able determine density GABA A receptor various Regions Interest measure PET analysis among group subject . This study provide new information concern localization degree dysfunction GABA-ergic neuron movement relate structure dystonia , might open new possibility pharmacological treatment disorder .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : A . Patients clinically document focal hand dystonia . This criterion establish preliminary screening NINDS Human Motor Control Section Outpatient Clinic . B . Patients ( male female ) range age 18 65 year age . Female patient childbearing potential pregnancy test , must negative interview prior study ensure pregnant patient participate study . Subjects ask abstain alcohol one week prior study . C. Twenty healthy volunteer include ; volunteer screen NINDS Human Motor Control Section Outpatient Clinic , neurological physical examination . Healthy volunteer chronic illness , take medication affect CNS exclude . Subjects ask abstain alcohol one week prior study . Female volunteer childbearing potential pregnancy test , must negative interview prior study ensure pregnant subject participate study . EXCLUSION CRITERIA : The following subject exclude : A . Subjects young 18 old 65 year old . B . Subjects MRI finding consistent brain tumor , stroke , trauma AVMs . C. Patients progressive neurological disorder dystonia . D. Subjects past present neuropsychiatric illness , head trauma loss consciousness , epilepsy , cerebrovascular disease , migraine , past present history alcohol abuse , medical condition may alter cerebral structure . E. Subjects cancer , except skin cancer . F. Subjects incapable give informed consent G. Subjects pregnant breastfeeding H. Patients currently benzodiazepines , bind GABAA receptor compete directly flumazenil binding ; baclofen bind GABAB receptor ; flunitrazepam , benzodiazepine receptor agonist ; triazolam , partial allosteric modulator GABA A receptor . Patients need medication four week prior enter study . I . Patients recent ( within 3 month ) BoTox injection . Botulinum Toxin A ( BoTox ) injection commonly use relieve pain muscle spasm dystonic patient . Participation Children Patients healthy subject young 18 year age exclude study due follow reason : ( ) Absorbed radiation dose per mCi relatively higher , pharmacodynamic effect great child compare adult . ( ii ) No direct benefit individual patient anticipate study . The study `` great minimal risk '' , thus meet criterion 45 CFR 46 Subpart D ( `` prospect direct benefit '' ) govern participation child research .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 14, 2010</verification_date>
	<keyword>Neurotransmitter</keyword>
	<keyword>Neuroimaging</keyword>
	<keyword>Movement Disorder</keyword>
	<keyword>Focal Hand Dystonia</keyword>
	<keyword>FHD</keyword>
	<keyword>HV</keyword>
</DOC>